Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-31

Reporting Person: HANDFORD RONALD L (Director, President/CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2003-12-31	Common Stock $0.001 par value	A	0	—	Acquired	0	Indirect
2003-12-31	Common Stock $0.001 par value	A	0	—	Disposed	908000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-12-31	Warrent	$0.75	A	0	Acquired	2005-12-01	Common Stock (0)	Direct
2003-12-16	Stock Options	$0.50	A	200000	Acquired	2011-12-16	Common Stock (200000)	Direct
2003-12-31	Stock Options	$1.00	A	0.00	Acquired	2005-10-01	Common Stock (0)	Direct

Footnotes

F1: Of the 908,000 shares of common stock reported as beneficially owned by Ronald L. Handford: (i) 100,000 shares are held of record by Handford Management Inc., over which Ronald L. Handford has sole voting and disposition rights; and (ii) 808,000 shares are held of record by Ronald L. Handford.

F2: Granted in accordance with the terms and provisions of the Stock Option Plan dated December 16, 2003, in consideration of services and duties performed.